Kiniksa Pharmaceuticals International, plc
KNSA
$56.51
-$2.03-3.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 164.57% | 259.75% | 245.24% | 556.29% | 148.23% |
| Total Depreciation and Amortization | 35.65% | 16.75% | -3.76% | -16.74% | -25.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.06% | 98.68% | 256.42% | -37.67% | -6.37% |
| Change in Net Operating Assets | 545.28% | 25.99% | -118.15% | 83.19% | -81.36% |
| Cash from Operations | 124.87% | 187.13% | 1,606.13% | 443.54% | 459.92% |
| Capital Expenditure | -62.63% | -227.98% | -- | -- | -17.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.27% | -207.17% | -878.01% | 92.06% | -300.88% |
| Cash from Investing | 38.08% | -208.46% | -888.58% | 91.70% | -301.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.91% | 215.29% | 72.88% | 1,022.91% | -20.38% |
| Repurchase of Common Stock | 23.30% | -58.82% | -60.51% | -55.90% | -8.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 119.40% | 257.52% | 77.89% | 6,110.11% | -23.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 192.09% | -110.74% | -806.54% | 183.49% | -179.85% |